March Monthly Research Highlights Newsletter
Cedars-SinaiA roundup of the latest medical discoveries and faculty news at Cedars-Sinai for March 2024.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for March 2024.
Um novo estudo da Mayo Clinic constatou que pessoas socialmente isoladas são mais propensas a apresentarem sinais de serem mais velhas biologicamente do que a sua verdadeira idade e mais propensas a morrerem por uma variedade de causas.
While pacemakers have been instrumental in treating many patients with heart rhythm disorders, their bulky design and dependence on wires can limit their usefulness and poses a risk of heart damage or infection. Researchers have cut the cords, shrunk the size, and expanded the capabilities of current designs.
Un nuevo estudio de Mayo Clinic constató que la gente socialmente aislada tiene más probabilidad de presentar signos de que sea biologicamente más vieja que su verdadera edad y más probabilidad de morir por una variedad de causas.
Experts advance models for speedy adoption for better diagnosis and therapy in The Lancet.
B-type natriuretic peptide (BNP) plays a key role in chronic itch severity and can help to identify certain types of itch with a simple blood test, according to a new study led by Gil Yosipovitch, M.D., director of the Miami Itch Center, and Santosh Mishra, Ph.D., a neuroscientist and associate professor at the North Carolina State College of Veterinary Medicine.
For outstanding contributions to engineering of biomimetic tissue-on-chip technologies and organoids for disease modeling and regenerative medicine, ASU's Mehdi Nikkhah has been inducted as a Fellow into the American Institute for Medical and Biomedical Engineering.
Media registration is now open for TCT 2024 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation (CRF).
Black patients in need of a heart transplant may be less likely to receive one than white patients, according to a new study led by Indiana University School of Medicine researchers.
UC San Diego Health is the first in San Diego to implant the world’s first dual chamber, leadless pacemaker system to help treat abnormal heart rhythms.
For soft tissue to recover and regrow, it needs blood vessels to grow to deliver oxygen and nutrients. Sluggish vascularization, however, can slow or even prevent recovery and regrowth of lost or damaged soft tissue after a severe injury or serious illness such as cancer.
A new study examining cholesteryl esters suggests that periods of prolonged inactivity may affect people differently depending on their age.
A new study from Mayo Clinic finds that socially isolated people are more likely to show signs of being biologically older than their age and more likely to die from a variety of causes.
As Rutgers' biomedical education, research and clinical care arm enters its second decade, new strategies are delivering healthier futures for New Jersey and beyond
The Megan Schulman Memorial Foundation Pledges Major Support to K. Hovnanian Children’s Hospital to Establish a Pediatric Vascular Anomalies Clinic
Nobel Laureate Brian Kobilka, MD, and NASA Astronaut Jessica Meir, PhD, are among the highlighted speakers who will attend the American Physiology Summit, the American Physiological Society’s (APS) flagship annual meeting.
Exercising during pregnancy doesn’t just benefit moms – it may also give their babies a head start on their heart health after birth, according to a study by researchers at The Ohio State University Wexner Medical Center.
Resmetirom (Rezdiffra) is the first drug approved for treating MASH, an advanced form of fatty liver disease. UChicago Medicine experts contributed to a recent clinical trial and will begin incorporating the drug into liver disease treatment regimens for eligible patients.
The UCLA Department of Medicine is pleased to announce that Priscilla Hsue, MD will be joining us as the chief of the Division of Cardiology at UCLA, effective July 1, 2024.
Researchers identified several differences in DNA methylation in people who experienced preeclampsia during pregnancy, according to a new study from Oregon Health & Science University.
Researchers at The Pennsylvania State University have developed a new synergistic approach to revascularization that could rapidly grow organized blood vessels in live rats.
The Suzie and Larry Johnson Foundation, gifted $10 million to support the health system’s Heart & Vascular Institute and Memorial Hermann Life Flight®, enabling the expansion of highly advanced cardiovascular and trauma care across the Greater Houston community.
New study finds that getting less than 45% of total energy from carbohydrates is not associated with elevated mortality risk compared with groups that consume more carbohydrates.
A insuficiência cardíaca é um problema de saúde potencialmente urgente para jovens adultos com doença cardíaca congênita (ACHD). Ela é frequentemente negligenciada e pouco tratada, apesar de as hospitalizações para esse problema continuarem aumentando. A pesquisa da Mayo Clinic revela que jovens adultos nos Estados Unidos que vivem com doença cardíaca congênita têm maior risco de morte ou complicações cardiovasculares após a hospitalização por insuficiência cardíaca. Entretanto, os dados do estudo publicados na revista médica Journal of the American Heart Association também descobriram que os pacientes que receberam cuidados cardiológicos recentes e antes da hospitalização por insuficiência cardíaca tinham menos probabilidade de morrer.
مدينة روتشستر، ولاية مينيسوتا – يشكّل فشل عضلة القلب مصدر قلق صحي ربما يكون مُلحًا بالنسبة للبالغين الشباب المصابين بمرض القلب الخلقي (ACHD) الذي يتم تجاهله وعدم التعامل معه بجدية في كثير من الأحيان، برغم استمرار تزايد عدد الحالات المحتجزة في المستشفيات بسبب هذا المرض. تبين الأبحاث الصادرة من مايو كلينك أن البالغين الشباب في الولايات المتحدة الذين يعيشون بمرض القلب الخلقي مُعرضون بشكل متزايد لخطر الوفاة أو لمضاعفات أمراض القلب والأوعية الدموية بعد احتجازهم في المستشفى للعلاج من فشل عضلة القلب. ومع ذلك، تبين بيانات الدراسة المنشورة في مجلة جمعية القلب الأمريكية أيضًا أن المرضى الذين كانوا يتلقون مؤخرًا رعاية طبية لأمراض القلب قبل احتجازهم في المستشفى لتلقي علاج فشل عضلة القلب كانوا أقل عُرضة للوفاة.
Hackensack Meridian Health experts can address concerns of recent study that found some patients with carotid stenosis have evidence of micoscopic particles from environmental plastics in their atherosclerotic plaque.
While lifesaving, bone marrow transplants can affect various organs, including the cardiovascular system. Researchers led by Michigan Medicine have not only determined the contemporary prevalence of cardiovascular complications after bone marrow transplant — they developed a novel tool to predict a person’s risk for such problems following the procedure and help guide the pre-transplant process.The work formed the basis of a scientific statement published by the American Health Association geared towards the cardiovascular management of patients undergoing bone marrow transplant.
In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.
La insuficiencia cardíaca es una preocupación de salud potencialmente urgente para los adultos jóvenes con enfermedad cardíaca congénita (ACHD, por sus siglas en inglés), una enfermedad a menudo subestimada e intratada, incluso cuando las hospitalizaciones para esta afección siguen en aumento.
The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the first on the West Coast to use a new device aimed at lowering blood pressure in patients with difficult-to-treat hypertension.
As an honoree, Dr. Salima Qamruddin was formally recognized at the 2024 “Go Red for Women” luncheon on Friday, March 1. The event, held at the Hilton Riverside, celebrated the accomplishments of all six “Women in STEM” honorees and encouraged continued advancements in the field.
The biggest decrease in age happened among Black men
Team studying predictive models for serious sleep condition awarded $3 million NIH grant
One in four older adults take aspirin at least three times a week, mostly in hopes of preventing heart attacks and strokes, a new poll shows. But many people aged 50 to 80 who said they take aspirin may not need to because hey don’t have a history of cardiovascular disease.
The risk of stroke tied to sleep apnea may vary for Black people and white people, according to a study published in the March 6, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
An injectable hydrogel can mitigate damage to the right ventricle of the heart with chronic pressure overload, according to a new study published March 6 in Journals of the American College of Cardiology: Basic to Translational Science. The study, by a research team from the University of California San Diego, Georgia Institute of Technology and Emory University, was conducted in rodents.
UNLV professor Thessa Hilgenkamp addresses the unique anatomy in adults with Down syndrome that makes being active more challenging.
Four University of Michigan research teams have made the bracket of 64 teams for STAT Madness, a virtual tournament of science. They were picked for their groundbreaking work on brain cancer, heart transplant, dementia care and deadly fungal infections published in 2023.
A new training protocol to assist first responders in recognizing and responding to symptoms of heart events in women is being rolled out.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for February 2024.
A study from New York Institute of Technology's Center for Esports Medicine analyzes whether compression sleeves worn below the knee or short walking breaks can enhance blood flow and reduce blood clot risk in gamers.
Cleveland Clinic Among First Hospitals to Perform New Tissue-Sparing Ablation Procedure
The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An international heart failure conference organized by the Cardiovascular Research Foundation® (CRF®), THT will take place March 4-6, 2024, at the Westin Boston Seaport in Boston, MA.